{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T02:20:44Z","timestamp":1782267644523,"version":"3.54.5"},"reference-count":15,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1016\/j.vaccine.2003.08.013","type":"journal-article","created":{"date-parts":[[2003,9,17]],"date-time":"2003-09-17T04:55:50Z","timestamp":1063774550000},"page":"4650-4654","source":"Crossref","is-referenced-by-count":10,"title":["A combined dual-chamber typhoid\/hepatitis A vaccine as a booster dose in hepatitis A primed adults"],"prefix":"10.1016","volume":"21","author":[{"given":"Ji\u0159\u0131\u0301","family":"Beran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Chlibek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2003.08.013_BIB1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00005792-199201000-00002","article-title":"Relapsing hepatitis A: review of 14 cases and literature survey","volume":"71","author":"Glikson","year":"1992","journal-title":"Medicine"},{"key":"10.1016\/j.vaccine.2003.08.013_BIB2","first-page":"10","article-title":"Hepatitis A in travellers: development of a safe, immunogenic and efficacious inactivated vaccine","volume":"13","author":"Andre","year":"1995","journal-title":"Travel Med. Int."},{"key":"10.1016\/j.vaccine.2003.08.013_BIB3","unstructured":"Anonymous. Typhoid vaccines\u2014WHO position paper. Wkly Epidemiol Rec 2000;75:257\u201364."},{"key":"10.1016\/j.vaccine.2003.08.013_BIB4","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/clinids\/24.Supplement_1.S106","article-title":"Multidrug-resistant Salmonella typhi: a world-wide epidemic","volume":"24","author":"Rowe","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.08.013_BIB5","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1001\/archinte.155.21.2293","article-title":"A new typhoid vaccine composed of the Vi capsular polysaccharide","volume":"155","author":"Plotkin","year":"1995","journal-title":"Arch. Int. Med."},{"key":"10.1016\/j.vaccine.2003.08.013_BIB6","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/jama.272.11.885","article-title":"Epidemiology and prevention of hepatitis A in travellers","volume":"272","author":"Steffen","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2003.08.013_BIB7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1708-8305.2002.tb00872.x","article-title":"Ineffectiveness of the current strategy to prevent hepatitis A in travellers","volume":"9","author":"De Serres","year":"2002","journal-title":"J. Travel Med."},{"key":"10.1016\/j.vaccine.2003.08.013_BIB8","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1708-8305.1998.tb00483.x","article-title":"Concomitant vaccination against hepatitis A and typhoid fever","volume":"5","author":"Van Hoecke","year":"1998","journal-title":"J. Travel Med."},{"key":"10.1016\/j.vaccine.2003.08.013_BIB9","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2310\/7060.2000.00073","article-title":"A single dose, combined vaccine against typhoid fever and hepatitis A: consistency, immunogenicity and reactogenicity","volume":"7","author":"Beran","year":"2000","journal-title":"J. Travel Med."},{"key":"10.1016\/j.vaccine.2003.08.013_BIB10","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2310\/7060.2002.23845","article-title":"Combined vaccination against hepatitis A, hepatitis B, and typhoid fever: safety, reactogenicity, and immunogenicity","volume":"9","author":"Proell","year":"2002","journal-title":"J. Travel Med."},{"key":"10.1016\/j.vaccine.2003.08.013_BIB11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1708-8305.1997.tb00796.x","article-title":"Immune response to hepatitis A vaccine combined or given simultaneously with typhoid fever vaccine","volume":"4","author":"Vodopija","year":"1997","journal-title":"J. Travel Med."},{"key":"10.1016\/j.vaccine.2003.08.013_BIB12","unstructured":"Overbosch D, Peyron F, Picot N, Varichon JP. Immunogenicity and safety of a combined typhoid fever and hepatitis A vaccine: a comparison of a combined vaccine in a dual-chamber syringe versus the monovalent vaccines. In: Proceedings of the Seventh International Conference of the International Society of Travel Medicine (Abstract FC07.03), 27\u201331 May 2001, lnnsbruck, Austria."},{"key":"10.1016\/j.vaccine.2003.08.013_BIB13","unstructured":"Beeching NJ, Clarke P, Walker E, et al. A comparison of two combined vaccines against typhoid fever and hepatitis A: Viatim\u2122 and Hepatyrix\u2122. In: Proceedings of the Fourth Scientific Conference of the British Travel Health Association. 2 March 2002, London, UK."},{"key":"10.1016\/j.vaccine.2003.08.013_BIB14","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/infdis\/154.2.342","article-title":"Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccines","volume":"154","author":"Tacket","year":"1986","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.08.013_BIB15","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/0264-410X(94)90267-4","article-title":"Combined vaccination against yellow fever and typhoid fever: a comparative trial","volume":"12","author":"Ambrosch","year":"1994","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03006030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03006030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,24]],"date-time":"2019-02-24T01:28:28Z","timestamp":1550971708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X03006030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":15,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["S0264410X03006030"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2003.08.013","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}